ME Therapeutics Holdings Inc (METX)

Currency in CAD
6.50
0.00(0.00%)
Closed·
METX Scorecard
Full Analysis
Significant return over the last week
METX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.506.50
52 wk Range
0.7511.00
Key Statistics
Bid/Ask
3.50 / 4.30
Prev. Close
3.8
Open
6.5
Day's Range
6.5-6.5
52 wk Range
0.75-11
Volume
100
Average Volume (3m)
701
1-Year Change
68.83%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
METX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

ME Therapeutics Holdings Inc Company Profile

ME Therapeutics Holdings Inc., a preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology. Its lead candidate, h1B11-12, is a glycoprotein cytokine antibody drug that targets a key protein involved in the generation of suppressive myeloid cells for the treatment of colorectal cancer. The company also develops D094 and D099, which are small molecule myeloid targeted prodrug candidates to treat cancer; and myeloid targeting lipid nanoparticles (LNPS) formulations. ME Therapeutics Holdings Inc. was founded in 2014 and is headquartered in Vancouver, Canada.

Compare METX to Peers and Sector

Metrics to compare
METX
Peers
Sector
Relationship
P/E Ratio
0.0x−2.3x−0.5x
PEG Ratio
0.00−0.010.00
Price/Book
0.0x1.3x2.6x
Price / LTM Sales
0.0x1.9x3.3x
Upside (Analyst Target)
0.0%224.2%43.4%
Fair Value Upside
Unlock−0.9%7.1%Unlock

Earnings

Latest Release
Jun 27, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

METX Income Statement

FAQ

What Stock Exchange Does ME Therapeutics Holdings Trade On?

ME Therapeutics Holdings is listed and trades on the Canadian Securities Exchange stock exchange.

What Is the Stock Symbol for ME Therapeutics Holdings?

The stock symbol for ME Therapeutics Holdings is "METX."

What Is the ME Therapeutics Holdings Market Cap?

As of today, ME Therapeutics Holdings market cap is 192.33M.

What Is ME Therapeutics Holdings's Earnings Per Share (TTM)?

The ME Therapeutics Holdings EPS (TTM) is -0.04.

From a Technical Analysis Perspective, Is METX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has ME Therapeutics Holdings Stock Split?

ME Therapeutics Holdings has split 0 times.

How Many Employees Does ME Therapeutics Holdings Have?

ME Therapeutics Holdings has 0 employees.

What is the current trading status of ME Therapeutics Holdings (METX)?

As of 10 Aug 2025, ME Therapeutics Holdings (METX) is trading at a price of 6.50, with a previous close of 3.80. The stock has fluctuated within a day range of 6.50 to 6.50, while its 52-week range spans from 0.75 to 11.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.